Toxicological evaluation of herbo-mineral formulation: Acute and sub-acute oral toxicity in rats

IF 2.1 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Mukul S. Tambe, Akshay M. Baheti, Arti G. Swami, Anil T. Pawar
{"title":"Toxicological evaluation of herbo-mineral formulation: Acute and sub-acute oral toxicity in rats","authors":"Mukul S. Tambe,&nbsp;Akshay M. Baheti,&nbsp;Arti G. Swami,&nbsp;Anil T. Pawar","doi":"10.1016/j.jaim.2026.101368","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Toxicity evaluation is an essential component of the preclinical safety assessment for herbal and herbo-mineral formulations intended for repeated use.</div></div><div><h3>Objectives</h3><div>The present study was undertaken to assess the acute and subacute oral toxicity of an Ayurveda-based herbo-mineral formulation (HMF) comprising <em>Tinospora cordifolia</em> (Thunb.) Miers, <em>Withania somnifera</em> (L.) Dunal, and <em>Kukkutandatvak bhasma</em> in rats.</div></div><div><h3>Methods</h3><div>An acute toxicity of a prepared HMF was conducted at a single oral dose of 2000 mg/kg in rats as per OECD guideline 423. Sub-acute toxicity of HMF was evaluated at 250, 500, and 1000 mg/kg by oral administration in rats in accordance with OECD Test Guideline 407.</div></div><div><h3>Results</h3><div>No mortality and clinical signs of toxicity were produced in rats by a single oral administration of a 2000 mg/kg dose of HMF. In the subacute toxicity study, body weight gain and food consumption patterns in the HMF-treated groups were comparable to those of the vehicle control group. Hematological and serum biochemical parameters remained within physiological limits. The relative organ weights did not differ significantly between the control and HMF-treated groups. Histopathological evaluation of the organs of HMF-treated rats revealed normal findings. No delayed or residual toxicity was observed in the satellite group.</div></div><div><h3>Conclusion</h3><div>HMF was found to be safe following a single 2000 mg/kg dose and at a 28-days repeated dose of 1000 mg/kg by the oral route in rats. The study findings support the safety of the HMF and provide a scientific basis for further preclinical and clinical development.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 4","pages":"Article 101368"},"PeriodicalIF":2.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0975947626000525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Toxicity evaluation is an essential component of the preclinical safety assessment for herbal and herbo-mineral formulations intended for repeated use.

Objectives

The present study was undertaken to assess the acute and subacute oral toxicity of an Ayurveda-based herbo-mineral formulation (HMF) comprising Tinospora cordifolia (Thunb.) Miers, Withania somnifera (L.) Dunal, and Kukkutandatvak bhasma in rats.

Methods

An acute toxicity of a prepared HMF was conducted at a single oral dose of 2000 mg/kg in rats as per OECD guideline 423. Sub-acute toxicity of HMF was evaluated at 250, 500, and 1000 mg/kg by oral administration in rats in accordance with OECD Test Guideline 407.

Results

No mortality and clinical signs of toxicity were produced in rats by a single oral administration of a 2000 mg/kg dose of HMF. In the subacute toxicity study, body weight gain and food consumption patterns in the HMF-treated groups were comparable to those of the vehicle control group. Hematological and serum biochemical parameters remained within physiological limits. The relative organ weights did not differ significantly between the control and HMF-treated groups. Histopathological evaluation of the organs of HMF-treated rats revealed normal findings. No delayed or residual toxicity was observed in the satellite group.

Conclusion

HMF was found to be safe following a single 2000 mg/kg dose and at a 28-days repeated dose of 1000 mg/kg by the oral route in rats. The study findings support the safety of the HMF and provide a scientific basis for further preclinical and clinical development.
草药矿物制剂的毒理学评价:大鼠急性和亚急性口服毒性。
背景:毒性评估是重复使用的草药和草药矿物制剂临床前安全性评估的重要组成部分。目的:本研究旨在评估一种以阿育吠陀为基础的含Tinospora cordifolia (Thunb)的草药矿物制剂(HMF)的急性和亚急性口服毒性。Miers, Withania somnifera (L.)Dunal和Kukkutandatvak bhasma。方法:按照OECD指南423,对制备的HMF单次口服剂量2000 mg/kg的大鼠进行急性毒性试验。按照OECD试验指南407,对大鼠口服HMF在250、500和1000 mg/kg时的亚急性毒性进行了评估。结果:单次口服2000 mg/kg剂量的HMF,大鼠无死亡和毒性临床症状。在亚急性毒性研究中,hmf处理组的体重增加和食物消耗模式与车辆对照组相当。血液学和血清生化指标保持在生理范围内。相对脏器重量在对照组和hmf处理组之间无显著差异。hmf处理大鼠的脏器组织病理学检查显示正常。卫星组未见延迟毒性或残留毒性。结论:大鼠单次给药2000 mg/kg和28 d重复给药1000 mg/kg是安全的。研究结果支持了HMF的安全性,并为进一步的临床前和临床开发提供了科学依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ayurveda and Integrative Medicine
Journal of Ayurveda and Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
12.50%
发文量
136
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书